Parthenon Therapeutics scoops up $65m Series A
Parthenon Therapeutics, a biotech company, has raised $65 million in Series A financing.
Parthenon Therapeutics, a biotech company, has raised $65 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination